Association of restrictive ventilatory dysfunction with insulin resistance and type 2 diabetes in Koreans

Experimental and Clinical Endocrinology and Diabetes

Volumn 119, Issue 1, 2011, Pages 47-52

  Kim, H K ^a   Kim, C H ^b   Jung, Y J ^a   Bae, S J ^a   Choe, J ^a   Park, J Y ^a   Lee, K U ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Soonchunhyang University   (South Korea)

Author keywords

insulin resistance; restrictive ventilatory dysfunction; type 2 diabetes mellitus

Indexed keywords

GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; DISEASE ASSOCIATION; FEMALE; FORCED EXPIRATORY VOLUME; FORCED EXPIRATORY VOLUME IN ONE SECOND; FORCED VITAL CAPACITY; HUMAN; IMPAIRED FASTING GLUCOSE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; KOREA; LOGISTIC REGRESSION ANALYSIS; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSTRUCTIVE AIRWAY DISEASE; PREVALENCE; PRIORITY JOURNAL; RESPIRATORY FAILURE; RESTRICTIVE VENTILATORY DYSFUNCTION; SMOKING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; COMORBIDITY; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INSULIN RESISTANCE; LUNG DISEASES; MALE; MIDDLE AGED; ODDS RATIO; PREVALENCE; REPUBLIC OF KOREA; RESPIRATORY FUNCTION TESTS;

EID: 78651423610     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0030-1268467     Document Type: Article

References (39)

1. Aaron SD, Dales RE, Cardinal P. How accurate is spirometry at predicting restrictive pulmonary impairment? Chest 1999 115 869-873
2. American Thoracic Society. Standardization of Spirometry, 1994 Update. Am J Respir Crit Care Med 1995 152 1107-1136
3. Bjorntorp P. The regulation of adipose tissue distribution in humans. Int J Obes Relat Metab Disord 1996 20 291-302
4. Bonora E, Kiechl S, Willeit J, etal. Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. Diabetes 1998 47 1643-1649
5. Canoy D, Luben R, Welch A, etal. Abdominal obesity and respiratory function in men and women in the EPIC-Norfolk Study, United Kingdom. Am J Epidemiol 2004 159 1140-1149
6. Choi JK, Paek DM, Lee JO. Normal predictive values of spirometry in Korean population. Tuberc Respir Dis 2005 58 230-242
7. Davis WA, Knuiman M, Kendall P, etal. Glycemic exposure is associated with reduced pulmonary function in type 2 diabetes: the Fremantle Diabetes Study. Diabetes Care 2004 27 752-757
8. Engstrom G, Hedblad B, Nilsson P, etal. Lung function, insulin resistance and incidence of cardiovascular disease: a longitudinal cohort study. J Intern Med 2003 253 574-581
9. Engstrom G, Janzon L. Risk of developing diabetes is inversely related to lung function: a population-based cohort study. Diabet Med 2002 19 167-170
10. Engstrom G, Lind P, Hedblad B, etal. Lung function and cardiovascular risk: relationship with inflammation-sensitive plasma proteins. Circulation 2002 106 2555-2560
11. Evans SE, Scanlon PD. Current practice in pulmonary function testing. Mayo Clin Proc 2003 78 758-763
12. Fabbri LM, Luppi F, Beghe B, etal. Complex chronic comorbidities of COPD. Eur Respir J 2008 31 204-212
13. Fabbri LM, Rabe KF. From COPD to chronic systemic inflammatory syndrome? Lancet 2007 370 797-799
14. Fimognari FL, Pasqualetti P, Moro L, etal. The association between metabolic syndrome and restrictive ventilatory dysfunction in older persons. J Gerontol Med Sci 2007 62 760-765
15. Ford ES. Leukocyte count, erythrocyte sedimentation rate, and diabetes incidence in a national sample of US adults. Am J Epidemiol 2002 155 57-64
16. Ford ES, Mannino DM. Prospective association between lung function and the incidence of diabetes: findings from the National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. Diabetes Care 2004 27 2966-2970
17. Gunnell D, Whitley E, Upton MN, etal. Associations of height, leg length, and lung function with cardiovascular risk factors in the Midspan Family Study. J Epidemiol Community Health 2003 57 141-146
18. Haffner SM, Miettinen H, Stern MP. The homeostasis model in the San Antonio Heart Study. Diabetes Care 1997 20 1087-1092
19. Hales CN, Barker DJ. The thrifty phenotype hypothesis. Br Med Bull 2001 60 5-20
20. Kouritas VK, Hatzoglou C, Ioannou M, etal. Insulin alters the permeability of sheep pleura. Exp Clin Endocrinol Diabetes 2010 118 304-309
21. Lange P, Parner J, Schnohr P, etal. Copenhagen City Heart Study: longitudinal analysis of ventilatory capacity in diabetic and nondiabetic adults. Eur Respir J 2002 20 1406-1412
22. Lawlor DA, Ebrahim S, Smith GD. Associations of measures of lung function with insulin resistance and Type 2 diabetes: findings from the British Women's Heart and Health Study. Diabetologia 2004 47 195-203
23. Lazarus R, Sparrow D, Weiss ST. Effects of obesity and fat distribution on ventilatory function: the Normative Aging Study. Chest 1997 111 891-898
24. Lazarus R, Sparrow D, Weiss ST. Baseline ventilatory function predicts the development of higher levels of fasting insulin and fasting insulin resistance index: the Normative Aging Study. Eur Respir J 1998 12 641-645
25. Leone N, Courbon D, Thomas F, etal. Lung function impairment and metabolic syndrome: the critical role of abdominal obesity. Am J Respir Crit Care Med 2009 179 509-516
26. Li AM, Chan D, Wong E, etal. The effects of obesity on pulmonary function. Arch Dis Child 2003 88 361-363
27. Lin WY, Yao CA, Wang HC, etal. Impaired lung function is associated with obesity and metabolic syndrome in adults. Obesity (Silver Spring) 2006 14 1654-1661
28. Litonjua AA, Lazarus R, Sparrow D, etal. Lung function in type 2 diabetes: the Normative Aging Study. Respir Med 2005 99 1583-1590
29. Mannino DM, Ford ES, Redd SC. Obstructive and restrictive lung disease and markers of inflammation: data from the Third National Health and Nutrition Examination. Am J Med 2003 114 758-762
30. Mannino DM, Thorn D, Swensen A, etal. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J 2008 32 962-969
31. Marvisi M, Bartolini L, del Borrello P, etal. Pulmonary function in non-insulin-dependent diabetes mellitus. Respiration 2001 68 268-272
32. Matthews DR, Hosker JP, Rudenski AS, etal. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 28 412-419
33. Mendall MA, Strachan DP, Butland BK, etal. C-reactive protein: relation to total mortality, cardiovascular mortality and cardiovascular risk factors in men. Eur Heart J 2000 21 1584-1590
34. Nakajima K, Kubouchi Y, Muneyuki T, etal. A possible association between suspected restrictive pattern as assessed by ordinary pulmonary function test and the metabolic syndrome. Chest 2008 134 712-718
35. Pradhan AD, Manson JE, Rifai N, etal. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001 286 327-334
36. Sandler M. Is the lung a target organ' in diabetes mellitus? Arch Intern Med 1990 150 1385-1388
37. Schmidt MI, Duncan BB, Sharrett AR, etal. Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study. Lancet 1999 353 1649-1652
38. Walter RE, Beiser A, Givelber RJ, etal. Association between glycemic state and lung function: the Framingham Heart Study. Am J Respir Crit Care Med 2003 167 911-916
39. Yeh HC, Punjabi NM, Wang NY, etal. Cross-sectional and prospective study of lung function in adults with type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) study. Diabetes Care 2008 31 741-746